PROFILE OF THE OPPOSITELY ACTING ENANTIOMERS OF THE DIHYDROPYRIDINE 202-791 IN CARDIAC PREPARATIONS - RECEPTOR-BINDING, ELECTROPHYSIOLOGICAL, AND PHARMACOLOGICAL STUDIES

被引:72
作者
WILLIAMS, JS
GRUPP, IL
GRUPP, G
VAGHY, PL
DUMONT, L
SCHWARTZ, A
YATANI, A
HAMILTON, S
BROWN, AM
机构
[1] UNIV CINCINNATI,COLL MED,DEPT PHYSIOL,CINCINNATI,OH 45267
[2] UNIV CINCINNATI,COLL MED,DEPT CELL BIOPHYS,CINCINNATI,OH 45267
[3] UNIV TEXAS,MED BRANCH,DEPT PHYSIOL & BIOPHYS,GALVESTON,TX 77550
关键词
D O I
10.1016/0006-291X(85)91763-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页码:13 / 21
页数:9
相关论文
共 20 条
[1]   NITRENDIPINE BLOCK OF CARDIAC CALCIUM CHANNELS - HIGH-AFFINITY BINDING TO THE INACTIVATED STATE [J].
BEAN, BP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1984, 81 (20) :6388-6392
[2]  
Bevington P., 1969, DATA REDUCTION ERROR
[3]   THE AGONIST EFFECT OF DIHYDROPYRIDINES ON CA-CHANNELS [J].
BROWN, AM ;
KUNZE, DL ;
YATANI, A .
NATURE, 1984, 311 (5986) :570-572
[4]  
BROWN AM, 1984, J PHYSIOL-LONDON, V357, pP59
[5]   EFFECT OF MEMBRANE DEPOLARIZATION ON BINDING OF [NITRENDIPINE-H-3 TO RAT CARDIAC MYOCYTES [J].
GREEN, FJ ;
FARMER, BB ;
WISEMAN, GL ;
JOSE, MJL ;
WATANABE, AM .
CIRCULATION RESEARCH, 1985, 56 (04) :576-585
[6]  
GRUPP IL, 1984, METHOD PHARMACOL, V5, P111
[7]   IMPROVED PATCH-CLAMP TECHNIQUES FOR HIGH-RESOLUTION CURRENT RECORDING FROM CELLS AND CELL-FREE MEMBRANE PATCHES [J].
HAMILL, OP ;
MARTY, A ;
NEHER, E ;
SAKMANN, B ;
SIGWORTH, FJ .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1981, 391 (02) :85-100
[8]   DIFFERENT MODES OF CA-CHANNEL GATING BEHAVIOR FAVORED BY DIHYDROPYRIDINE CA-AGONISTS AND ANTAGONISTS [J].
HESS, P ;
LANSMAN, JB ;
TSIEN, RW .
NATURE, 1984, 311 (5986) :538-544
[9]   SIMULTANEOUS ASSESSMENT OF EFFECTS OF CORONARY VASODILATORS ON CORONARY BLOOD-FLOW AND MYOCARDIAL-CONTRACTILITY BY USING BLOOD-PERFUSED CANINE PAPILLARY-MUSCLE [J].
HIMORI, N ;
ONO, H ;
TAIRA, N .
JAPANESE JOURNAL OF PHARMACOLOGY, 1976, 26 (04) :427-435
[10]  
HOF RP, 1985, J CARDIOVASC PHARM